Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The pathological hallmark of
Parkinson's disease
is cell death of dopaminergic neurons in the substantia nigra, resulting in striatal dopaminergic deficit and a clinical syndrome dominated by disorders of movement. The cause for this cell loss is unknown, but the possibility of a contributing genetic factor is increasingly recognized. Homozygous weaver mice, a mutant mouse strain, display progressive postnatal depletion of dopaminergic cells in the mesencephalon and have thus been proposed as an animal model for
Parkinson's disease
. Recently, mGIRK2, a putative G-protein inward rectifier K+ channel, has been identified as the causative gene in the weaver mouse and a homozygous mutation has been described in the H5 pore region of this channel. The human homologue of mGIRK2,
KCNJ7
or hiGIRK2, has previously been isolated on chromosome 21q22.1. A possible involvement of this gene in the pathogenesis of
Parkinson's disease
has been discussed. To evaluate the possibility of a shared genetic defect in weaver mouse and
Parkinson's disease
, we analysed the H5 pore region of hiGIRK2 in familial and sporadic cases of
Parkinson's disease
. The sequence was normal in all cases examined, suggesting a differing aetiology of nigral cell loss in
Parkinson's disease
and weaver mice.
...
PMID:The human homologue of the weaver mouse gene in familial and sporadic Parkinson's disease. 873 15